Healthcare Triangle Inc (HCTI)vs10X Genomics Inc (TXG)
HCTI
Healthcare Triangle Inc
$1.21
-30.06%
HEALTHCARE · Cap: $2.53M
TXG
10X Genomics Inc
$56.09
-3.54%
HEALTHCARE · Cap: $7.31B
Smart Verdict
WallStSmart Research — data-driven comparison
10X Genomics Inc generates 2978% more annual revenue ($616.91M vs $20.04M). TXG leads profitability with a -12.2% profit margin vs -69.7%. HCTI earns a higher WallStSmart Score of 41/100 (D).
HCTI
Hold41
out of 100
Grade: D
TXG
Avoid20
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for HCTI.
Margin of Safety
+65.9%
Fair Value
$56.16
Current Price
$56.09
$0.07 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Revenue surging 166.1% year-over-year
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
ROE of -26.5% — below average capital efficiency
Trading at 8.9x book value
0.0% earnings growth
Weak financial health signals
ROE of -2.8% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : HCTI
The strongest argument for HCTI centers on Price/Book, Revenue Growth, Debt/Equity. Revenue growth of 166.1% demonstrates continued momentum.
Bull Case : TXG
The strongest argument for TXG centers on Debt/Equity.
Bear Case : HCTI
The primary concerns for HCTI are EPS Growth, Market Cap, Piotroski F-Score.
Bear Case : TXG
The primary concerns for TXG are Price/Book, EPS Growth, Piotroski F-Score.
Key Dynamics to Monitor
HCTI profiles as a hypergrowth stock while TXG is a turnaround play — different risk/reward profiles.
TXG carries more volatility with a beta of 2.04 — expect wider price swings.
HCTI is growing revenue faster at 166.1% — sustainability is the question.
TXG generates stronger free cash flow (15M), providing more financial flexibility.
Bottom Line
HCTI scores higher overall (41/100 vs 20/100) and 166.1% revenue growth. TXG offers better value entry with a 65.9% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Healthcare Triangle Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Healthcare Triangle, Inc. is a healthcare information technology company. The company is headquartered in Pleasanton, California.
10X Genomics Inc
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and Asia Pacific. The company is headquartered in Pleasanton, California.
Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?